How personal loss and hope drove Elaine Maynard’s work in clinical trials and patient-centric technologies

Citius Pharma receives FDA approval for immunotherapy targeting rare blood cancer

Halda Therapeutics raises $126M to take 'hold and kill' precision cancer drugs to the clinic

Gilead gains accelerated FDA approval for rare liver disease treatment

FDA lifts hold on BioNTech and MediLink's ADC trial After safety revisions

Breakthrough delivery system could transform Alzheimer’s treatment

First bispecific CAR-T therapy for MS receives green light from FDA to start phase 1

Breaking News: Lecanemab approved in UK but unavailable on NHS

Highlights

array(40) {
  [0]=>
  string(4) "1739"
  ["article_id"]=>
  string(4) "1739"
  [1]=>
  string(62) "Colorectal cancer screening and the role of community pharmacy"
  ["article_title"]=>
  string(62) "Colorectal cancer screening and the role of community pharmacy"
  [2]=>
  string(148) "Access to colorectal cancer screening varies across the UK. This article describes the various tests and how community pharmacists can promote them."
  ["short_description"]=>
  string(148) "Access to colorectal cancer screening varies across the UK. This article describes the various tests and how community pharmacists can promote them."
  [3]=>
  string(148) "Access to colorectal cancer screening varies across the UK. This article describes the various tests and how community pharmacists can promote them."
  ["description"]=>
  string(148) "Access to colorectal cancer screening varies across the UK. This article describes the various tests and how community pharmacists can promote them."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "12"
  ["rss_id"]=>
  string(2) "12"
  [14]=>
  string(144) "https://www.pharmaceutical-journal.com/learning/learning-article/colorectal-cancer-screening-and-the-role-of-community-pharmacy/20205674.article"
  ["blog_url"]=>
  string(144) "https://www.pharmaceutical-journal.com/learning/learning-article/colorectal-cancer-screening-and-the-role-of-community-pharmacy/20205674.article"
  [15]=>
  string(19) "2019-01-23 22:05:00"
  ["add_date"]=>
  string(19) "2019-01-23 22:05:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:37"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:37"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Colorectal cancer screening and the role of community pharmacy

Access to colorectal cancer screening varies across the UK. This article describes the various tests and how community p

array(40) {
  [0]=>
  string(4) "1755"
  ["article_id"]=>
  string(4) "1755"
  [1]=>
  string(107) "Biohaven Receives FDA May Proceed Letter For Phase 3 Clinical Trial Of BHV-3241 For Multiple System Atrophy"
  ["article_title"]=>
  string(107) "Biohaven Receives FDA May Proceed Letter For Phase 3 Clinical Trial Of BHV-3241 For Multiple System Atrophy"
  [2]=>
  string(150) "NEW HAVEN, Conn., Jan. 23, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven") announced today the U"
  ["short_description"]=>
  string(150) "NEW HAVEN, Conn., Jan. 23, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven") announced today the U"
  [3]=>
  string(245) "NEW HAVEN, Conn., Jan. 23, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven") announced today the U.S. Food and Drug Administration (FDA) has notified the Company that it may proceed with its..."
  ["description"]=>
  string(245) "NEW HAVEN, Conn., Jan. 23, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven") announced today the U.S. Food and Drug Administration (FDA) has notified the Company that it may proceed with its..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(289) "https://www.drugs.com/clinical_trials/biohaven-receives-fda-may-proceed-letter-phase-3-clinical-trial-bhv-3241-multiple-atrophy-18065.html?utm_source=ddc&utm_medium=rss&utm_campaign=Biohaven+Receives+FDA+May+Proceed+Letter+For+Phase+3+Clinical+Trial+Of+BHV-3241+For+Multiple+System+Atrophy"
  ["blog_url"]=>
  string(289) "https://www.drugs.com/clinical_trials/biohaven-receives-fda-may-proceed-letter-phase-3-clinical-trial-bhv-3241-multiple-atrophy-18065.html?utm_source=ddc&utm_medium=rss&utm_campaign=Biohaven+Receives+FDA+May+Proceed+Letter+For+Phase+3+Clinical+Trial+Of+BHV-3241+For+Multiple+System+Atrophy"
  [15]=>
  string(19) "2019-01-23 10:01:59"
  ["add_date"]=>
  string(19) "2019-01-23 10:01:59"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:38"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:38"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Biohaven Receives FDA May Proceed Letter For Phase 3 Clinical Trial Of BHV-3241 For Multip

NEW HAVEN, Conn., Jan. 23, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohave

array(40) {
  [0]=>
  string(4) "1710"
  ["article_id"]=>
  string(4) "1710"
  [1]=>
  string(115) "FDA Approves Use of 0.5 mL Dose of Fluzone Quadrivalent (influenza vaccine) in Children as Young as 6 Months of Age"
  ["article_title"]=>
  string(115) "FDA Approves Use of 0.5 mL Dose of Fluzone Quadrivalent (influenza vaccine) in Children as Young as 6 Months of Age"
  [2]=>
  string(150) "BRIDGEWATER, N.J., Jan. 23, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has approved the use of the 0.5 mL dose of Fluzone Quadrivalent"
  ["short_description"]=>
  string(150) "BRIDGEWATER, N.J., Jan. 23, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has approved the use of the 0.5 mL dose of Fluzone Quadrivalent"
  [3]=>
  string(246) "BRIDGEWATER, N.J., Jan. 23, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has approved the use of the 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) to include children age 6 through 35 months. Sanofi Pasteur, the vaccine..."
  ["description"]=>
  string(246) "BRIDGEWATER, N.J., Jan. 23, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has approved the use of the 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) to include children age 6 through 35 months. Sanofi Pasteur, the vaccine..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "8"
  ["rss_id"]=>
  string(1) "8"
  [14]=>
  string(290) "https://www.drugs.com/newdrugs/fda-approves-0-5-ml-fluzone-quadrivalent-influenza-vaccine-children-young-6-months-age-4908.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Approves+Use+of+0.5+mL+Dose+of+Fluzone+Quadrivalent+%28influenza+vaccine%29+in+Children+as+Young+as+6+Months+of+Age"
  ["blog_url"]=>
  string(290) "https://www.drugs.com/newdrugs/fda-approves-0-5-ml-fluzone-quadrivalent-influenza-vaccine-children-young-6-months-age-4908.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Approves+Use+of+0.5+mL+Dose+of+Fluzone+Quadrivalent+%28influenza+vaccine%29+in+Children+as+Young+as+6+Months+of+Age"
  [15]=>
  string(19) "2019-01-23 08:01:27"
  ["add_date"]=>
  string(19) "2019-01-23 08:01:27"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:34"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

FDA Approves Use of 0.5 mL Dose of Fluzone Quadrivalent (influenza vaccine) in Children as

BRIDGEWATER, N.J., Jan. 23, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has approved the use of the 0.5 m

array(40) {
  [0]=>
  string(4) "5335"
  ["article_id"]=>
  string(4) "5335"
  [1]=>
  string(78) "BIT’s 13thWorld Congress of Regenerative Medicine & Stem Cell"
  ["article_title"]=>
  string(78) "BIT’s 13thWorld Congress of Regenerative Medicine & Stem Cell"
  [2]=>
  string(167) "Event title: BIT’s 13thWorld Congress of Regenerative Medicine & Stem Cell&#nl&#nlhttp://www.bitcongress.com/rmsc2019/&#nl&#nlHosting Organization: Info"
  ["short_description"]=>
  string(167) "Event title: BIT’s 13thWorld Congress of Regenerative Medicine & Stem Cell&#nl&#nlhttp://www.bitcongress.com/rmsc2019/&#nl&#nlHosting Organization: Info"
  [3]=>
  string(594) "Event title: BIT’s 13thWorld Congress of Regenerative Medicine & Stem Cell&#nl&#nlhttp://www.bitcongress.com/rmsc2019/&#nl&#nlHosting Organization: Information Research Center of International Talent, China State Administration of Foreign Experts Affairs, China&#nl&#nlOperating Organization: BIT Group Global Ltd.&#nl&#nlTel: 0086-411-84799609-813&#nl&#nlFax: 0086-411-84575250&#nl&#nlEmail: emma@rmsccongress.com&#nl&#nl710000&#nl&#nl &#nl&#nlTheme: Regeneration, Wisdom, Healthy, Wealthy and Solemn Life&#nl&#nl &#nl&#nlDalian — the "Northern Pearl" and su..."
  ["description"]=>
  string(594) "Event title: BIT’s 13thWorld Congress of Regenerative Medicine & Stem Cell&#nl&#nlhttp://www.bitcongress.com/rmsc2019/&#nl&#nlHosting Organization: Information Research Center of International Talent, China State Administration of Foreign Experts Affairs, China&#nl&#nlOperating Organization: BIT Group Global Ltd.&#nl&#nlTel: 0086-411-84799609-813&#nl&#nlFax: 0086-411-84575250&#nl&#nlEmail: emma@rmsccongress.com&#nl&#nl710000&#nl&#nl &#nl&#nlTheme: Regeneration, Wisdom, Healthy, Wealthy and Solemn Life&#nl&#nl &#nl&#nlDalian — the "Northern Pearl" and su..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(95) "https://www.pharmiweb.com/event/bitâ-s-13thworld-congress-of-regenerative-medicine-stem-cell"
  ["blog_url"]=>
  string(95) "https://www.pharmiweb.com/event/bitâ-s-13thworld-congress-of-regenerative-medicine-stem-cell"
  [15]=>
  string(19) "2019-01-22 10:25:03"
  ["add_date"]=>
  string(19) "2019-01-22 10:25:03"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-10-31 15:50:28"
  ["create_at"]=>
  string(19) "2019-10-31 15:50:28"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

BIT’s 13thWorld Congress of Regenerative Medicine & Stem Cell

Event title: BIT’s 13thWorld Congress of Regenerative Medicine & Stem Cell&#nl&#nlhttp://www.bitcongress.

array(40) {
  [0]=>
  string(4) "1703"
  ["article_id"]=>
  string(4) "1703"
  [1]=>
  string(170) "UPDATED: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP"
  ["article_title"]=>
  string(170) "UPDATED: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP"
  [2]=>
  string(150) "Audience: Consumer, Health Professional, Pharmacy. Torrent Pharmaceuticals Limited is expanding its voluntary recall from 10 lots of Losartan potassiu"
  ["short_description"]=>
  string(150) "Audience: Consumer, Health Professional, Pharmacy. Torrent Pharmaceuticals Limited is expanding its voluntary recall from 10 lots of Losartan potassiu"
  [3]=>
  string(251) "Audience: Consumer, Health Professional, Pharmacy. Torrent Pharmaceuticals Limited is expanding its voluntary recall from 10 lots of Losartan potassium tablets USP to include 6 lots of Losartan potassium and hydrochlorothiazide tablets, USP, to the..."
  ["description"]=>
  string(251) "Audience: Consumer, Health Professional, Pharmacy. Torrent Pharmaceuticals Limited is expanding its voluntary recall from 10 lots of Losartan potassium tablets USP to include 6 lots of Losartan potassium and hydrochlorothiazide tablets, USP, to the..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "7"
  ["rss_id"]=>
  string(1) "7"
  [14]=>
  string(300) "https://www.drugs.com/fda/updated-torrent-pharmaceuticals-limited-issues-voluntary-nationwide-recall-losartan-potassium-usp-14238.html?utm_source=ddc&utm_medium=rss&utm_campaign=UPDATED%3A+Torrent+Pharmaceuticals+Limited+Issues+Voluntary+Nationwide+Recall+of+Losartan+Potassium+Tablets%2C+USP+and+Los"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/fda/updated-torrent-pharmaceuticals-limited-issues-voluntary-nationwide-recall-losartan-potassium-usp-14238.html?utm_source=ddc&utm_medium=rss&utm_campaign=UPDATED%3A+Torrent+Pharmaceuticals+Limited+Issues+Voluntary+Nationwide+Recall+of+Losartan+Potassium+Tablets%2C+USP+and+Los"
  [15]=>
  string(19) "2019-01-22 08:00:00"
  ["add_date"]=>
  string(19) "2019-01-22 08:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:34"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

UPDATED: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Po

Audience: Consumer, Health Professional, Pharmacy. Torrent Pharmaceuticals Limited is expanding its voluntary recall fro

array(40) {
  [0]=>
  string(4) "1715"
  ["article_id"]=>
  string(4) "1715"
  [1]=>
  string(110) "Amgen And UCB Receive Positive Vote From FDA Advisory Committee In Favor Of Approval For Evenity (romosozumab)"
  ["article_title"]=>
  string(110) "Amgen And UCB Receive Positive Vote From FDA Advisory Committee In Favor Of Approval For Evenity (romosozumab)"
  [2]=>
  string(150) "THOUSAND OAKS, Calif. and BRUSSELS, Jan. 16, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) today announced strong support "
  ["short_description"]=>
  string(150) "THOUSAND OAKS, Calif. and BRUSSELS, Jan. 16, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) today announced strong support "
  [3]=>
  string(248) "THOUSAND OAKS, Calif. and BRUSSELS, Jan. 16, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) today announced strong support from the U.S. Food and Drug Administration (FDA) Bone, Reproductive and Urologic Drugs Advisory..."
  ["description"]=>
  string(248) "THOUSAND OAKS, Calif. and BRUSSELS, Jan. 16, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) today announced strong support from the U.S. Food and Drug Administration (FDA) Bone, Reproductive and Urologic Drugs Advisory..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "9"
  ["rss_id"]=>
  string(1) "9"
  [14]=>
  string(203) "https://www.drugs.com/nda/evenity_190121.html?utm_source=ddc&utm_medium=rss&utm_campaign=Amgen+And+UCB+Receive+Positive+Vote+From+FDA+Advisory+Committee+In+Favor+Of+Approval+For+Evenity+%28romosozumab%29"
  ["blog_url"]=>
  string(203) "https://www.drugs.com/nda/evenity_190121.html?utm_source=ddc&utm_medium=rss&utm_campaign=Amgen+And+UCB+Receive+Positive+Vote+From+FDA+Advisory+Committee+In+Favor+Of+Approval+For+Evenity+%28romosozumab%29"
  [15]=>
  string(19) "2019-01-22 04:01:19"
  ["add_date"]=>
  string(19) "2019-01-22 04:01:19"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:34"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Amgen And UCB Receive Positive Vote From FDA Advisory Committee In Favor Of Approval For E

THOUSAND OAKS, Calif. and BRUSSELS, Jan. 16, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) t

array(40) {
  [0]=>
  string(4) "1740"
  ["article_id"]=>
  string(4) "1740"
  [1]=>
  string(89) "Joerg Reinhardt: 'A career in industry demands authenticity, candour and courage'"
  ["article_title"]=>
  string(89) "Joerg Reinhardt: 'A career in industry demands authenticity, candour and courage'"
  [2]=>
  string(155) "Pharmacist and chair of the board of directors for Novartis, Joerg Reinhardt, sits down with the Royal Pharmaceutical Society’s chief scientist, Gin"
  ["short_description"]=>
  string(155) "Pharmacist and chair of the board of directors for Novartis, Joerg Reinhardt, sits down with the Royal Pharmaceutical Society’s chief scientist, Gin"
  [3]=>
  string(290) "Pharmacist and chair of the board of directors for Novartis, Joerg Reinhardt, sits down with the Royal Pharmaceutical Society’s chief scientist, Gino Martini, to discuss his career success to date, the challenges facing the pharmaceutical industry and his future vision for Novartis."
  ["description"]=>
  string(290) "Pharmacist and chair of the board of directors for Novartis, Joerg Reinhardt, sits down with the Royal Pharmaceutical Society’s chief scientist, Gino Martini, to discuss his career success to date, the challenges facing the pharmaceutical industry and his future vision for Novartis."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "12"
  ["rss_id"]=>
  string(2) "12"
  [14]=>
  string(177) "https://www.pharmaceutical-journal.com/careers-and-jobs/careers-and-jobs/career-qa/joerg-reinhardt-a-career-in-industry-demands-authenticity-candour-and-courage/20206027.article"
  ["blog_url"]=>
  string(177) "https://www.pharmaceutical-journal.com/careers-and-jobs/careers-and-jobs/career-qa/joerg-reinhardt-a-career-in-industry-demands-authenticity-candour-and-courage/20206027.article"
  [15]=>
  string(19) "2019-01-21 17:50:00"
  ["add_date"]=>
  string(19) "2019-01-21 17:50:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:37"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:37"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Joerg Reinhardt: 'A career in industry demands authenticity, candour and courage'

Pharmacist and chair of the board of directors for Novartis, Joerg Reinhardt, sits down with the Royal Pharmaceutical So

array(40) {
  [0]=>
  string(4) "2191"
  ["article_id"]=>
  string(4) "2191"
  [1]=>
  string(85) "Samsung Bioepis’ trastuzumab biosimilar receives approval in the United States"
  ["article_title"]=>
  string(85) "Samsung Bioepis’ trastuzumab biosimilar receives approval in the United States"
  [2]=>
  string(152) "Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Ontruzant (trastuzumab-dttb).  Ontruzant is a biosi"
  ["short_description"]=>
  string(152) "Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Ontruzant (trastuzumab-dttb).  Ontruzant is a biosi"
  [3]=>
  string(771) "Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Ontruzant (trastuzumab-dttb).  Ontruzant is a biosimilar referencing Herceptin (trastuzumab), across all eligible indications, namely adjuvant treatment of HER2-overexpressing breast cancer, metastatic breast cancer and metastatic gastric cancer or gastroesophageal junction adenocarcinoma in patients who have not received prior treatment for metastatic disease. Ontruzant is Samsung Bioepis’ first oncology biosimilar to receive FDA approval, and will be marketed and distributed in the United States (US) by Merck, […]""/"
  ["description"]=>
  string(771) "Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Ontruzant (trastuzumab-dttb).  Ontruzant is a biosimilar referencing Herceptin (trastuzumab), across all eligible indications, namely adjuvant treatment of HER2-overexpressing breast cancer, metastatic breast cancer and metastatic gastric cancer or gastroesophageal junction adenocarcinoma in patients who have not received prior treatment for metastatic disease. Ontruzant is Samsung Bioepis’ first oncology biosimilar to receive FDA approval, and will be marketed and distributed in the United States (US) by Merck, […]""/"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "43"
  ["rss_id"]=>
  string(2) "43"
  [14]=>
  string(61) "http://feedproxy.google.com/~r/BiosimilarNews/~3/jEjYst8hZ2U/"
  ["blog_url"]=>
  string(61) "http://feedproxy.google.com/~r/BiosimilarNews/~3/jEjYst8hZ2U/"
  [15]=>
  string(19) "2019-01-21 17:01:25"
  ["add_date"]=>
  string(19) "2019-01-21 17:01:25"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:41"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Samsung Bioepis’ trastuzumab biosimilar receives approval in the United States

Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Ontruzant (trastuzumab

array(40) {
  [0]=>
  string(4) "1596"
  ["article_id"]=>
  string(4) "1596"
  [1]=>
  string(51) "Shoes Make the Difference When Starting to Exercise"
  ["article_title"]=>
  string(51) "Shoes Make the Difference When Starting to Exercise"
  [2]=>
  string(161) "SATURDAY, Jan. 19, 2019 -- If you've vowed to be more active this year, be sure you have proper athletic shoes, a doctor suggests.&#nl"The right shoe is "
  ["short_description"]=>
  string(161) "SATURDAY, Jan. 19, 2019 -- If you've vowed to be more active this year, be sure you have proper athletic shoes, a doctor suggests.&#nl"The right shoe is "
  [3]=>
  string(266) "SATURDAY, Jan. 19, 2019 -- If you've vowed to be more active this year, be sure you have proper athletic shoes, a doctor suggests.&#nl"The right shoe is important for a runner as much as a good tennis racket is important for a tennis player," said Dr...."
  ["description"]=>
  string(266) "SATURDAY, Jan. 19, 2019 -- If you've vowed to be more active this year, be sure you have proper athletic shoes, a doctor suggests.&#nl"The right shoe is important for a runner as much as a good tennis racket is important for a tennis player," said Dr...."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(172) "https://www.drugs.com/news/shoes-make-difference-starting-exercise-79855.html?utm_source=ddc&utm_medium=rss&utm_campaign=Shoes+Make+the+Difference+When+Starting+to+Exercise"
  ["blog_url"]=>
  string(172) "https://www.drugs.com/news/shoes-make-difference-starting-exercise-79855.html?utm_source=ddc&utm_medium=rss&utm_campaign=Shoes+Make+the+Difference+When+Starting+to+Exercise"
  [15]=>
  string(19) "2019-01-19 17:00:38"
  ["add_date"]=>
  string(19) "2019-01-19 17:00:38"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Shoes Make the Difference When Starting to Exercise

SATURDAY, Jan. 19, 2019 -- If you've vowed to be more active this year, be sure you have proper athletic shoes, a do

array(40) {
  [0]=>
  string(4) "1616"
  ["article_id"]=>
  string(4) "1616"
  [1]=>
  string(53) "Mandibular Contour Surgery Training System Beneficial"
  ["article_title"]=>
  string(53) "Mandibular Contour Surgery Training System Beneficial"
  [2]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- An intraoral mandibular contour surgery (MCS) training system is effective for improving clinical surgery time and accuracy, "
  ["short_description"]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- An intraoral mandibular contour surgery (MCS) training system is effective for improving clinical surgery time and accuracy, "
  [3]=>
  string(254) "FRIDAY, Jan. 18, 2019 -- An intraoral mandibular contour surgery (MCS) training system is effective for improving clinical surgery time and accuracy, according to a study published online Jan. 17 in JAMA Facial Plastic Surgery.&#nlJia Qiao, M.D., from..."
  ["description"]=>
  string(254) "FRIDAY, Jan. 18, 2019 -- An intraoral mandibular contour surgery (MCS) training system is effective for improving clinical surgery time and accuracy, according to a study published online Jan. 17 in JAMA Facial Plastic Surgery.&#nlJia Qiao, M.D., from..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(181) "https://www.drugs.com/news/mandibular-contour-surgery-training-beneficial-79853.html?utm_source=ddc&utm_medium=rss&utm_campaign=Mandibular+Contour+Surgery+Training+System+Beneficial"
  ["blog_url"]=>
  string(181) "https://www.drugs.com/news/mandibular-contour-surgery-training-beneficial-79853.html?utm_source=ddc&utm_medium=rss&utm_campaign=Mandibular+Contour+Surgery+Training+System+Beneficial"
  [15]=>
  string(19) "2019-01-19 03:00:59"
  ["add_date"]=>
  string(19) "2019-01-19 03:00:59"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Mandibular Contour Surgery Training System Beneficial

FRIDAY, Jan. 18, 2019 -- An intraoral mandibular contour surgery (MCS) training system is effective for improving clinic

array(40) {
  [0]=>
  string(4) "1617"
  ["article_id"]=>
  string(4) "1617"
  [1]=>
  string(66) "Assessing Symptoms After 4 Weeks of Psychotherapy Helpful in Teens"
  ["article_title"]=>
  string(66) "Assessing Symptoms After 4 Weeks of Psychotherapy Helpful in Teens"
  [2]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- Therapists implementing interpersonal psychotherapy for depressed adolescents (IPT-A) should routinely monitor depression sym"
  ["short_description"]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- Therapists implementing interpersonal psychotherapy for depressed adolescents (IPT-A) should routinely monitor depression sym"
  [3]=>
  string(242) "FRIDAY, Jan. 18, 2019 -- Therapists implementing interpersonal psychotherapy for depressed adolescents (IPT-A) should routinely monitor depression symptoms and consider augmenting treatment for insufficient responders as early as week 4 of..."
  ["description"]=>
  string(242) "FRIDAY, Jan. 18, 2019 -- Therapists implementing interpersonal psychotherapy for depressed adolescents (IPT-A) should routinely monitor depression symptoms and consider augmenting treatment for insufficient responders as early as week 4 of..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(199) "https://www.drugs.com/news/assessing-after-4-weeks-psychotherapy-helpful-teens-79850.html?utm_source=ddc&utm_medium=rss&utm_campaign=Assessing+Symptoms+After+4+Weeks+of+Psychotherapy+Helpful+in+Teens"
  ["blog_url"]=>
  string(199) "https://www.drugs.com/news/assessing-after-4-weeks-psychotherapy-helpful-teens-79850.html?utm_source=ddc&utm_medium=rss&utm_campaign=Assessing+Symptoms+After+4+Weeks+of+Psychotherapy+Helpful+in+Teens"
  [15]=>
  string(19) "2019-01-19 03:00:57"
  ["add_date"]=>
  string(19) "2019-01-19 03:00:57"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Assessing Symptoms After 4 Weeks of Psychotherapy Helpful in Teens

FRIDAY, Jan. 18, 2019 -- Therapists implementing interpersonal psychotherapy for depressed adolescents (IPT-A) should ro

array(40) {
  [0]=>
  string(4) "1618"
  ["article_id"]=>
  string(4) "1618"
  [1]=>
  string(49) "Wait Times Have Improved in VA Health Care System"
  ["article_title"]=>
  string(49) "Wait Times Have Improved in VA Health Care System"
  [2]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- From 2014 to 2017, there were improvements in wait times in the Department of Veterans Affairs (VA) health care system, resul"
  ["short_description"]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- From 2014 to 2017, there were improvements in wait times in the Department of Veterans Affairs (VA) health care system, resul"
  [3]=>
  string(250) "FRIDAY, Jan. 18, 2019 -- From 2014 to 2017, there were improvements in wait times in the Department of Veterans Affairs (VA) health care system, resulting in reduced wait times versus the private sector (PS) in 2017, according to a study published..."
  ["description"]=>
  string(250) "FRIDAY, Jan. 18, 2019 -- From 2014 to 2017, there were improvements in wait times in the Department of Veterans Affairs (VA) health care system, resulting in reduced wait times versus the private sector (PS) in 2017, according to a study published..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(170) "https://www.drugs.com/news/wait-times-have-improved-va-health-care-79854.html?utm_source=ddc&utm_medium=rss&utm_campaign=Wait+Times+Have+Improved+in+VA+Health+Care+System"
  ["blog_url"]=>
  string(170) "https://www.drugs.com/news/wait-times-have-improved-va-health-care-79854.html?utm_source=ddc&utm_medium=rss&utm_campaign=Wait+Times+Have+Improved+in+VA+Health+Care+System"
  [15]=>
  string(19) "2019-01-19 03:00:52"
  ["add_date"]=>
  string(19) "2019-01-19 03:00:52"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Wait Times Have Improved in VA Health Care System

FRIDAY, Jan. 18, 2019 -- From 2014 to 2017, there were improvements in wait times in the Department of Veterans Affairs